A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of a single dosage strength of
GW685698/GW642444 in subjects with Chronic Obstructive Pulmonary Disease (COPD).